AKT1 and melanoma: CH depletion using agents like methyl-cyclodextrin (MCD) inhibits melanoma progression by disrupting AKT signaling Via Src kinase inactivation and PP2A phosphatase reactivation, inducing apoptosis, altering cell morphology, and impairing migration [172,173,174].